Example-BundleSummaryNotes
This shows an example summary notes.
| Bundle |
| meta |
| extension |
| extension |
| url : msgId |
| value |
| system : https://fhir.synapxe.sg/NamingSystem/msg-id |
| value : CR001 |
| extension |
| url : msgSequenceId |
| value |
| system : https://fhir.synapxe.sg/NamingSystem/msg-sequence-id |
| value : 001 |
| extension |
| url : date |
| value : 2026-04-01T15:00:00+08:00 |
| url : https://fhir.synapxe.sg/StructureDefinition/ext-artifact |
| source : HPB-IDEAS |
| profile : https://fhir.synapxe.sg/StructureDefinition/profile-bundle-composition |
| tag |
| code : TTSH |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/record-id |
| value : SN-REC-2026-01001 |
| type : document |
| timestamp : 2026-04-01T15:00:00+08:00 |
| entry |
| fullUrl : a3f5c8d2-1e4b-4a7f-9b2c-6d8e0f3a5b7c |
| resource |
| id : a3f5c8d2-1e4b-4a7f-9b2c-6d8e0f3a5b7c |
| meta |
| profile : https://fhir.synapxe.sg/StructureDefinition/profile-composition |
| text |
| status : generated |
| extension |
| url : https://fhir.synapxe.sg/StructureDefinition/ext-recorder |
| value |
| system : https://fhir.synapxe.sg/NamingSystem/mcr |
| value : M88888 |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/record-id |
| value : SN-REC-2026-01001 |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/accession-no |
| value : SN-ACC-2026-01001 |
| status : final |
| type |
| extension |
| url : https://fhir.synapxe.sg/StructureDefinition/ext-version |
| value : 1.0 |
| coding |
| system : http://loinc.org |
| code : 18761-7 |
| display : Transfer summary note |
| subject |
| type : Patient |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/nric |
| value : S7654321B |
| encounter |
| type : Encounter |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/event-id |
| value : SN-ENC-2026-01001 |
| date : 2026-03-19T14:30:00+08:00 |
| author |
| type : Practitioner |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/mcr |
| value : M88888 |
| title : Diabetes Management Summary Notes - Quarterly Review |
| note |
| text : Patient presented for quarterly diabetes management review. HbA1c at target. Continue current medication regimen with lifestyle modifications. |
| attester |
| mode |
| coding |
| system : http://hl7.org/fhir/CodeSystem/composition-attestation-mode |
| code : official |
| display : Official |
| time : 2026-03-19T14:30:00+08:00 |
| party |
| type : Practitioner |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/mcr |
| value : M88888 |
| display : Dr. Priya Reddy |
| custodian |
| type : Organization |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/hci-code |
| value : HCI-11111 |
| display : Tan Tock Seng Hospital |
| event |
| detail |
| reference |
| reference : c1a9b3e5-2f7d-4c8a-b4e0-9d3f6a2b5c8e |
| section |
| code |
| coding |
| system : http://loinc.org |
| code : 34895-3 |
| display : Diagnostic evidence documents |
| entry |
| reference : d4c7f2a8-3e1b-4d9c-a5f3-0b7e4c1a6d2f |
| section |
| code |
| coding |
| system : http://loinc.org |
| code : 30954-2 |
| display : Relevant diagnostic tests and laboratory data |
| entry |
| reference : e8b5a3f7-4d2c-4e0b-8f6a-1c9d3b7e5a2c |
| section |
| code |
| coding |
| system : http://loinc.org |
| code : 29548-5 |
| display : Diagnosis |
| entry |
| reference : f2d8c6b4-5a3e-4f1d-9a7b-2e0c8f4d1b6a |
| entry |
| fullUrl : b7e2d4f1-8c3a-4b6e-8d9f-2a0c5e7b1d4f |
| resource |
| id : b7e2d4f1-8c3a-4b6e-8d9f-2a0c5e7b1d4f |
| meta |
| profile : https://fhir.synapxe.sg/StructureDefinition/profile-practitionerrole |
| practitioner |
| type : Practitioner |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/mcr |
| value : M88888 |
| display : Dr. Priya Reddy |
| organization |
| type : Organization |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/hci-code |
| value : HCI-11111 |
| display : Tan Tock Seng Hospital |
| code |
| coding |
| system : http://snomed.info/sct |
| code : 83273008 |
| display : Endocrinologist |
| specialty |
| coding |
| system : http://snomed.info/sct |
| code : 394584008 |
| display : Endocrinology |
| entry |
| fullUrl : c1a9b3e5-2f7d-4c8a-b4e0-9d3f6a2b5c8e |
| resource |
| id : c1a9b3e5-2f7d-4c8a-b4e0-9d3f6a2b5c8e |
| meta |
| profile : https://fhir.synapxe.sg/StructureDefinition/profile-sn-procedure |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/procedure-id |
| value : PROC-SN-2026-01001 |
| status : completed |
| code |
| coding |
| system : http://snomed.info/sct |
| code : 38842003 |
| display : Patient consultation |
| subject |
| type : Patient |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/nric |
| value : S7654321B |
| encounter |
| type : Encounter |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/event-id |
| value : SN-ENC-2026-01001 |
| occurrence : 2026-03-19T14:00:00+08:00 |
| performer |
| actor |
| type : Practitioner |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/mcr |
| value : M88888 |
| reason |
| concept |
| coding |
| system : http://snomed.info/sct |
| code : 44054006 |
| display : Type 2 diabetes mellitus |
| outcome |
| text : Consultation completed. Diabetes control adequate with current medication regimen. |
| note |
| text : Patient compliant with medications. Blood pressure and lipid levels well-controlled. Continue metformin and linagliptin. Reinforce dietary modifications and regular exercise. |
| entry |
| fullUrl : d4c7f2a8-3e1b-4d9c-a5f3-0b7e4c1a6d2f |
| resource |
| id : d4c7f2a8-3e1b-4d9c-a5f3-0b7e4c1a6d2f |
| meta |
| profile : https://fhir.synapxe.sg/StructureDefinition/profile-sn-diagnosticreport |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/report-id |
| value : REP-SN-2026-01001 |
| status : final |
| category |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v2-0074 |
| code : CH |
| display : Chemistry |
| code |
| coding |
| system : http://loinc.org |
| code : 24365-2 |
| display : Comprehensive metabolic panel |
| effective : 2026-03-19T09:00:00+08:00 |
| issued : 2026-03-19T12:00:00+08:00 |
| performer |
| type : Practitioner |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/mcr |
| value : M99999 |
| conclusion : HbA1c 6.8% - within target range. Fasting glucose 118 mg/dL. Renal function normal. Lipid panel acceptable with current statin therapy. |
| entry |
| fullUrl : e8b5a3f7-4d2c-4e0b-8f6a-1c9d3b7e5a2c |
| resource |
| id : e8b5a3f7-4d2c-4e0b-8f6a-1c9d3b7e5a2c |
| meta |
| profile : https://fhir.synapxe.sg/StructureDefinition/profile-sn-observation |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/investigation-id |
| value : OBS-SN-2026-01001 |
| status : final |
| category |
| coding |
| system : http://terminology.hl7.org/CodeSystem/observation-category |
| code : laboratory |
| display : Laboratory |
| code |
| coding |
| system : http://loinc.org |
| code : 4548-4 |
| display : Hemoglobin A1c |
| issued : 2026-03-19T12:00:00+08:00 |
| performer |
| type : Practitioner |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/mcr |
| value : M99999 |
| display : Dr. Lee Wei |
| value |
| value : 6.8 |
| unit : % |
| system : http://unitsofmeasure.org |
| code : % |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : H |
| display : High |
| note |
| text : HbA1c well controlled and approaching therapeutic target of <7.0%. |
| referenceRange |
| low |
| value : 0 |
| unit : % |
| high |
| value : 5.7 |
| unit : % |
| entry |
| fullUrl : f2d8c6b4-5a3e-4f1d-9a7b-2e0c8f4d1b6a |
| resource |
| id : f2d8c6b4-5a3e-4f1d-9a7b-2e0c8f4d1b6a |
| meta |
| profile : https://fhir.synapxe.sg/StructureDefinition/profile-sn-condition |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/condition-id |
| value : COND-SN-2026-01001 |
| clinicalStatus |
| coding |
| system : http://terminology.hl7.org/CodeSystem/condition-clinical |
| code : active |
| display : Active |
| verificationStatus |
| coding |
| system : http://terminology.hl7.org/CodeSystem/condition-ver-status |
| code : confirmed |
| display : Confirmed |
| category |
| coding |
| system : http://terminology.hl7.org/CodeSystem/condition-category |
| code : problem-list-item |
| display : Problem List Item |
| severity |
| coding |
| system : http://snomed.info/sct |
| code : 371923003 |
| display : Mild |
| code |
| coding |
| system : http://snomed.info/sct |
| code : 44054006 |
| display : Type 2 diabetes mellitus |
| subject |
| type : Patient |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/nric |
| value : S7654321B |
| encounter |
| type : Encounter |
| identifier |
| system : https://fhir.synapxe.sg/NamingSystem/event-id |
| value : SN-ENC-2026-01001 |
| onset : 2018-06-15T00:00:00+08:00 |
| note |
| text : Type 2 diabetes diagnosed 8 years ago. Currently managed with metformin and linagliptin. Well-controlled with HbA1c at target. No current complications or comorbidities noted. |
| Bundle.meta[0].extension[0].extension[0].url[0] | msgId |
| Bundle.meta[0].extension[0].extension[0].value[0].system[0] | https://fhir.synapxe.sg/NamingSystem/msg-id |
| Bundle.meta[0].extension[0].extension[0].value[0].value[0] | CR001 |
| Bundle.meta[0].extension[0].extension[1].url[0] | msgSequenceId |
| Bundle.meta[0].extension[0].extension[1].value[0].system[0] | https://fhir.synapxe.sg/NamingSystem/msg-sequence-id |
| Bundle.meta[0].extension[0].extension[1].value[0].value[0] | 001 |
| Bundle.meta[0].extension[0].extension[2].url[0] | date |
| Bundle.meta[0].extension[0].extension[2].value[0] | 2026-04-01T15:00:00+08:00 |
| Bundle.meta[0].extension[0].url[0] | https://fhir.synapxe.sg/StructureDefinition/ext-artifact |
| Bundle.meta[0].source[0] | HPB-IDEAS |
| Bundle.meta[0].profile[0] | https://fhir.synapxe.sg/StructureDefinition/profile-bundle-composition |
| Bundle.meta[0].tag[0].code[0] | TTSH |
| Bundle.identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/record-id |
| Bundle.identifier[0].value[0] | SN-REC-2026-01001 |
| Bundle.type[0] | document |
| Bundle.timestamp[0] | 2026-04-01T15:00:00+08:00 |
| Bundle.entry[0].fullUrl[0] | a3f5c8d2-1e4b-4a7f-9b2c-6d8e0f3a5b7c |
| Bundle.entry[0].resource[0].id[0] | a3f5c8d2-1e4b-4a7f-9b2c-6d8e0f3a5b7c |
| Bundle.entry[0].resource[0].meta[0].profile[0] | https://fhir.synapxe.sg/StructureDefinition/profile-composition |
| Bundle.entry[0].resource[0].text[0].status[0] | generated |
| Bundle.entry[0].resource[0].text[0].div[0] | <div xmlns="http://www.w3.org/1999/xhtml">Example Summary Notes</div> |
| Bundle.entry[0].resource[0].extension[0].url[0] | https://fhir.synapxe.sg/StructureDefinition/ext-recorder |
| Bundle.entry[0].resource[0].extension[0].value[0].system[0] | https://fhir.synapxe.sg/NamingSystem/mcr |
| Bundle.entry[0].resource[0].extension[0].value[0].value[0] | M88888 |
| Bundle.entry[0].resource[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/record-id |
| Bundle.entry[0].resource[0].identifier[0].value[0] | SN-REC-2026-01001 |
| Bundle.entry[0].resource[0].identifier[1].system[0] | https://fhir.synapxe.sg/NamingSystem/accession-no |
| Bundle.entry[0].resource[0].identifier[1].value[0] | SN-ACC-2026-01001 |
| Bundle.entry[0].resource[0].status[0] | final |
| Bundle.entry[0].resource[0].type[0].extension[0].url[0] | https://fhir.synapxe.sg/StructureDefinition/ext-version |
| Bundle.entry[0].resource[0].type[0].extension[0].value[0] | 1.0 |
| Bundle.entry[0].resource[0].type[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[0].resource[0].type[0].coding[0].code[0] | 18761-7 |
| Bundle.entry[0].resource[0].type[0].coding[0].display[0] | Transfer summary note |
| Bundle.entry[0].resource[0].subject[0].type[0] | Patient |
| Bundle.entry[0].resource[0].subject[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/nric |
| Bundle.entry[0].resource[0].subject[0].identifier[0].value[0] | S7654321B |
| Bundle.entry[0].resource[0].encounter[0].type[0] | Encounter |
| Bundle.entry[0].resource[0].encounter[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/event-id |
| Bundle.entry[0].resource[0].encounter[0].identifier[0].value[0] | SN-ENC-2026-01001 |
| Bundle.entry[0].resource[0].date[0] | 2026-03-19T14:30:00+08:00 |
| Bundle.entry[0].resource[0].author[0].type[0] | Practitioner |
| Bundle.entry[0].resource[0].author[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/mcr |
| Bundle.entry[0].resource[0].author[0].identifier[0].value[0] | M88888 |
| Bundle.entry[0].resource[0].title[0] | Diabetes Management Summary Notes - Quarterly Review |
| Bundle.entry[0].resource[0].note[0].text[0] | Patient presented for quarterly diabetes management review. HbA1c at target. Continue current medication regimen with lifestyle modifications. |
| Bundle.entry[0].resource[0].attester[0].mode[0].coding[0].system[0] | http://hl7.org/fhir/CodeSystem/composition-attestation-mode |
| Bundle.entry[0].resource[0].attester[0].mode[0].coding[0].code[0] | official |
| Bundle.entry[0].resource[0].attester[0].mode[0].coding[0].display[0] | Official |
| Bundle.entry[0].resource[0].attester[0].time[0] | 2026-03-19T14:30:00+08:00 |
| Bundle.entry[0].resource[0].attester[0].party[0].type[0] | Practitioner |
| Bundle.entry[0].resource[0].attester[0].party[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/mcr |
| Bundle.entry[0].resource[0].attester[0].party[0].identifier[0].value[0] | M88888 |
| Bundle.entry[0].resource[0].attester[0].party[0].display[0] | Dr. Priya Reddy |
| Bundle.entry[0].resource[0].custodian[0].type[0] | Organization |
| Bundle.entry[0].resource[0].custodian[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/hci-code |
| Bundle.entry[0].resource[0].custodian[0].identifier[0].value[0] | HCI-11111 |
| Bundle.entry[0].resource[0].custodian[0].display[0] | Tan Tock Seng Hospital |
| Bundle.entry[0].resource[0].event[0].detail[0].reference[0].reference[0] | c1a9b3e5-2f7d-4c8a-b4e0-9d3f6a2b5c8e |
| Bundle.entry[0].resource[0].section[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[0].resource[0].section[0].code[0].coding[0].code[0] | 34895-3 |
| Bundle.entry[0].resource[0].section[0].code[0].coding[0].display[0] | Diagnostic evidence documents |
| Bundle.entry[0].resource[0].section[0].entry[0].reference[0] | d4c7f2a8-3e1b-4d9c-a5f3-0b7e4c1a6d2f |
| Bundle.entry[0].resource[0].section[1].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[0].resource[0].section[1].code[0].coding[0].code[0] | 30954-2 |
| Bundle.entry[0].resource[0].section[1].code[0].coding[0].display[0] | Relevant diagnostic tests and laboratory data |
| Bundle.entry[0].resource[0].section[1].entry[0].reference[0] | e8b5a3f7-4d2c-4e0b-8f6a-1c9d3b7e5a2c |
| Bundle.entry[0].resource[0].section[2].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[0].resource[0].section[2].code[0].coding[0].code[0] | 29548-5 |
| Bundle.entry[0].resource[0].section[2].code[0].coding[0].display[0] | Diagnosis |
| Bundle.entry[0].resource[0].section[2].entry[0].reference[0] | f2d8c6b4-5a3e-4f1d-9a7b-2e0c8f4d1b6a |
| Bundle.entry[1].fullUrl[0] | b7e2d4f1-8c3a-4b6e-8d9f-2a0c5e7b1d4f |
| Bundle.entry[1].resource[0].id[0] | b7e2d4f1-8c3a-4b6e-8d9f-2a0c5e7b1d4f |
| Bundle.entry[1].resource[0].meta[0].profile[0] | https://fhir.synapxe.sg/StructureDefinition/profile-practitionerrole |
| Bundle.entry[1].resource[0].practitioner[0].type[0] | Practitioner |
| Bundle.entry[1].resource[0].practitioner[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/mcr |
| Bundle.entry[1].resource[0].practitioner[0].identifier[0].value[0] | M88888 |
| Bundle.entry[1].resource[0].practitioner[0].display[0] | Dr. Priya Reddy |
| Bundle.entry[1].resource[0].organization[0].type[0] | Organization |
| Bundle.entry[1].resource[0].organization[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/hci-code |
| Bundle.entry[1].resource[0].organization[0].identifier[0].value[0] | HCI-11111 |
| Bundle.entry[1].resource[0].organization[0].display[0] | Tan Tock Seng Hospital |
| Bundle.entry[1].resource[0].code[0].coding[0].system[0] | http://snomed.info/sct |
| Bundle.entry[1].resource[0].code[0].coding[0].code[0] | 83273008 |
| Bundle.entry[1].resource[0].code[0].coding[0].display[0] | Endocrinologist |
| Bundle.entry[1].resource[0].specialty[0].coding[0].system[0] | http://snomed.info/sct |
| Bundle.entry[1].resource[0].specialty[0].coding[0].code[0] | 394584008 |
| Bundle.entry[1].resource[0].specialty[0].coding[0].display[0] | Endocrinology |
| Bundle.entry[2].fullUrl[0] | c1a9b3e5-2f7d-4c8a-b4e0-9d3f6a2b5c8e |
| Bundle.entry[2].resource[0].id[0] | c1a9b3e5-2f7d-4c8a-b4e0-9d3f6a2b5c8e |
| Bundle.entry[2].resource[0].meta[0].profile[0] | https://fhir.synapxe.sg/StructureDefinition/profile-sn-procedure |
| Bundle.entry[2].resource[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/procedure-id |
| Bundle.entry[2].resource[0].identifier[0].value[0] | PROC-SN-2026-01001 |
| Bundle.entry[2].resource[0].status[0] | completed |
| Bundle.entry[2].resource[0].code[0].coding[0].system[0] | http://snomed.info/sct |
| Bundle.entry[2].resource[0].code[0].coding[0].code[0] | 38842003 |
| Bundle.entry[2].resource[0].code[0].coding[0].display[0] | Patient consultation |
| Bundle.entry[2].resource[0].subject[0].type[0] | Patient |
| Bundle.entry[2].resource[0].subject[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/nric |
| Bundle.entry[2].resource[0].subject[0].identifier[0].value[0] | S7654321B |
| Bundle.entry[2].resource[0].encounter[0].type[0] | Encounter |
| Bundle.entry[2].resource[0].encounter[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/event-id |
| Bundle.entry[2].resource[0].encounter[0].identifier[0].value[0] | SN-ENC-2026-01001 |
| Bundle.entry[2].resource[0].occurrence[0] | 2026-03-19T14:00:00+08:00 |
| Bundle.entry[2].resource[0].performer[0].actor[0].type[0] | Practitioner |
| Bundle.entry[2].resource[0].performer[0].actor[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/mcr |
| Bundle.entry[2].resource[0].performer[0].actor[0].identifier[0].value[0] | M88888 |
| Bundle.entry[2].resource[0].reason[0].concept[0].coding[0].system[0] | http://snomed.info/sct |
| Bundle.entry[2].resource[0].reason[0].concept[0].coding[0].code[0] | 44054006 |
| Bundle.entry[2].resource[0].reason[0].concept[0].coding[0].display[0] | Type 2 diabetes mellitus |
| Bundle.entry[2].resource[0].outcome[0].text[0] | Consultation completed. Diabetes control adequate with current medication regimen. |
| Bundle.entry[2].resource[0].note[0].text[0] | Patient compliant with medications. Blood pressure and lipid levels well-controlled. Continue metformin and linagliptin. Reinforce dietary modifications and regular exercise. |
| Bundle.entry[3].fullUrl[0] | d4c7f2a8-3e1b-4d9c-a5f3-0b7e4c1a6d2f |
| Bundle.entry[3].resource[0].id[0] | d4c7f2a8-3e1b-4d9c-a5f3-0b7e4c1a6d2f |
| Bundle.entry[3].resource[0].meta[0].profile[0] | https://fhir.synapxe.sg/StructureDefinition/profile-sn-diagnosticreport |
| Bundle.entry[3].resource[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/report-id |
| Bundle.entry[3].resource[0].identifier[0].value[0] | REP-SN-2026-01001 |
| Bundle.entry[3].resource[0].status[0] | final |
| Bundle.entry[3].resource[0].category[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v2-0074 |
| Bundle.entry[3].resource[0].category[0].coding[0].code[0] | CH |
| Bundle.entry[3].resource[0].category[0].coding[0].display[0] | Chemistry |
| Bundle.entry[3].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[3].resource[0].code[0].coding[0].code[0] | 24365-2 |
| Bundle.entry[3].resource[0].code[0].coding[0].display[0] | Comprehensive metabolic panel |
| Bundle.entry[3].resource[0].effective[0] | 2026-03-19T09:00:00+08:00 |
| Bundle.entry[3].resource[0].issued[0] | 2026-03-19T12:00:00+08:00 |
| Bundle.entry[3].resource[0].performer[0].type[0] | Practitioner |
| Bundle.entry[3].resource[0].performer[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/mcr |
| Bundle.entry[3].resource[0].performer[0].identifier[0].value[0] | M99999 |
| Bundle.entry[3].resource[0].conclusion[0] | HbA1c 6.8% - within target range. Fasting glucose 118 mg/dL. Renal function normal. Lipid panel acceptable with current statin therapy. |
| Bundle.entry[4].fullUrl[0] | e8b5a3f7-4d2c-4e0b-8f6a-1c9d3b7e5a2c |
| Bundle.entry[4].resource[0].id[0] | e8b5a3f7-4d2c-4e0b-8f6a-1c9d3b7e5a2c |
| Bundle.entry[4].resource[0].meta[0].profile[0] | https://fhir.synapxe.sg/StructureDefinition/profile-sn-observation |
| Bundle.entry[4].resource[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/investigation-id |
| Bundle.entry[4].resource[0].identifier[0].value[0] | OBS-SN-2026-01001 |
| Bundle.entry[4].resource[0].status[0] | final |
| Bundle.entry[4].resource[0].category[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/observation-category |
| Bundle.entry[4].resource[0].category[0].coding[0].code[0] | laboratory |
| Bundle.entry[4].resource[0].category[0].coding[0].display[0] | Laboratory |
| Bundle.entry[4].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[4].resource[0].code[0].coding[0].code[0] | 4548-4 |
| Bundle.entry[4].resource[0].code[0].coding[0].display[0] | Hemoglobin A1c |
| Bundle.entry[4].resource[0].issued[0] | 2026-03-19T12:00:00+08:00 |
| Bundle.entry[4].resource[0].performer[0].type[0] | Practitioner |
| Bundle.entry[4].resource[0].performer[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/mcr |
| Bundle.entry[4].resource[0].performer[0].identifier[0].value[0] | M99999 |
| Bundle.entry[4].resource[0].performer[0].display[0] | Dr. Lee Wei |
| Bundle.entry[4].resource[0].value[0].value[0] | 6.8 |
| Bundle.entry[4].resource[0].value[0].unit[0] | % |
| Bundle.entry[4].resource[0].value[0].system[0] | http://unitsofmeasure.org |
| Bundle.entry[4].resource[0].value[0].code[0] | % |
| Bundle.entry[4].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[4].resource[0].interpretation[0].coding[0].code[0] | H |
| Bundle.entry[4].resource[0].interpretation[0].coding[0].display[0] | High |
| Bundle.entry[4].resource[0].note[0].text[0] | HbA1c well controlled and approaching therapeutic target of <7.0%. |
| Bundle.entry[4].resource[0].referenceRange[0].low[0].value[0] | 0 |
| Bundle.entry[4].resource[0].referenceRange[0].low[0].unit[0] | % |
| Bundle.entry[4].resource[0].referenceRange[0].high[0].value[0] | 5.7 |
| Bundle.entry[4].resource[0].referenceRange[0].high[0].unit[0] | % |
| Bundle.entry[5].fullUrl[0] | f2d8c6b4-5a3e-4f1d-9a7b-2e0c8f4d1b6a |
| Bundle.entry[5].resource[0].id[0] | f2d8c6b4-5a3e-4f1d-9a7b-2e0c8f4d1b6a |
| Bundle.entry[5].resource[0].meta[0].profile[0] | https://fhir.synapxe.sg/StructureDefinition/profile-sn-condition |
| Bundle.entry[5].resource[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/condition-id |
| Bundle.entry[5].resource[0].identifier[0].value[0] | COND-SN-2026-01001 |
| Bundle.entry[5].resource[0].clinicalStatus[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/condition-clinical |
| Bundle.entry[5].resource[0].clinicalStatus[0].coding[0].code[0] | active |
| Bundle.entry[5].resource[0].clinicalStatus[0].coding[0].display[0] | Active |
| Bundle.entry[5].resource[0].verificationStatus[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/condition-ver-status |
| Bundle.entry[5].resource[0].verificationStatus[0].coding[0].code[0] | confirmed |
| Bundle.entry[5].resource[0].verificationStatus[0].coding[0].display[0] | Confirmed |
| Bundle.entry[5].resource[0].category[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/condition-category |
| Bundle.entry[5].resource[0].category[0].coding[0].code[0] | problem-list-item |
| Bundle.entry[5].resource[0].category[0].coding[0].display[0] | Problem List Item |
| Bundle.entry[5].resource[0].severity[0].coding[0].system[0] | http://snomed.info/sct |
| Bundle.entry[5].resource[0].severity[0].coding[0].code[0] | 371923003 |
| Bundle.entry[5].resource[0].severity[0].coding[0].display[0] | Mild |
| Bundle.entry[5].resource[0].code[0].coding[0].system[0] | http://snomed.info/sct |
| Bundle.entry[5].resource[0].code[0].coding[0].code[0] | 44054006 |
| Bundle.entry[5].resource[0].code[0].coding[0].display[0] | Type 2 diabetes mellitus |
| Bundle.entry[5].resource[0].subject[0].type[0] | Patient |
| Bundle.entry[5].resource[0].subject[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/nric |
| Bundle.entry[5].resource[0].subject[0].identifier[0].value[0] | S7654321B |
| Bundle.entry[5].resource[0].encounter[0].type[0] | Encounter |
| Bundle.entry[5].resource[0].encounter[0].identifier[0].system[0] | https://fhir.synapxe.sg/NamingSystem/event-id |
| Bundle.entry[5].resource[0].encounter[0].identifier[0].value[0] | SN-ENC-2026-01001 |
| Bundle.entry[5].resource[0].onset[0] | 2018-06-15T00:00:00+08:00 |
| Bundle.entry[5].resource[0].note[0].text[0] | Type 2 diabetes diagnosed 8 years ago. Currently managed with metformin and linagliptin. Well-controlled with HbA1c at target. No current complications or comorbidities noted. |
{
{
{
}
},
{
}
},
{
}
],
}
],
"https://fhir.synapxe.sg/StructureDefinition/profile-bundle-composition"
],
]
},
},
{
},
},
{
}
}
],
{
},
{
}
],
],
]
},
{
}
}
],
}
},
{
}
}
],
{
"text": "Patient presented for quarterly diabetes management review. HbA1c at target. Continue current medication regimen with lifestyle modifications."
}
],
{
{
}
]
},
},
}
}
],
},
},
],
{
]
},
]
},
{
{
}
]
},
]
},
{
},
]
}
]
}
},
{
},
},
},
},
},
{
]
}
],
{
]
}
]
}
},
{
},
],
]
},
}
},
}
},
{
}
}
}
],
{
]
}
}
],
},
{
"text": "Patient compliant with medications. Blood pressure and lipid levels well-controlled. Continue metformin and linagliptin. Reinforce dietary modifications and regular exercise."
}
]
}
},
{
},
],
{
]
}
],
]
},
{
}
}
],
"conclusion": "HbA1c 6.8% - within target range. Fasting glucose 118 mg/dL. Renal function normal. Lipid panel acceptable with current statin therapy."
}
},
{
},
],
{
{
}
]
}
],
},
{
},
}
],
},
{
{
}
]
}
],
],
]
}
},
{
},
],
{
}
]
},
{
}
]
},
{
{
}
]
}
],
},
]
},
}
},
}
},
{
"text": "Type 2 diabetes diagnosed 8 years ago. Currently managed with metformin and linagliptin. Well-controlled with HbA1c at target. No current complications or comorbidities noted."
}
]
}
}
]
}